Scientists retool CAR T cells to serve as 'micropharmacies' for cancer drugs
Immunotherapies called chimeric antigen receptor (CAR) T cells use genetically engineered versions of a patient's own immune cells to fight cancer. These treatments have energized cancer care, especially for people with certain ...
Dec 30, 2021
0
172